0000000001070937
AUTHOR
Daniel S. Zaharko
Observations on the effects of cyclophosphamide, phosphoramide mustard and some activated oxazaphosphorines on murine L1210 leukemia.
The L1210 tumor system was used in vitro and in vivo in comparative studies with activated cyclophosphamide analogs, cyclophosphamide and phosphoramide mustard. All the above compounds gave substantial cell kills (5 logs) of L1210 in vivo at doses that were non-toxic, but slight differences were noted. ASTA Z 7557 had a slight advantage in cure rate over cyclophosphamide when these drugs were given i.v. or i.p. to early tumor (i.p.). However, cyclophosphamide had the advantage in cure rate when drug administration was i.v. to advanced tumor. At equimolar concentrations in vitro ASTA Z 7557 was more cytotoxic than either phosphoramide mustard or acrolein. In vivo, the activated cyclophospham…
Synthesis and characterization of polymeric derivatives of the folic acid antagonist, Methotrexate, N-[4-(N-methyl-2,4-diamino-6-pteridinylmethylamino)benzoyl] glutamic acid (1a), a widely used antitumor agent, are described. Derivatives of poly(L-lysine), poly(iminoethylene), poly(vinyl alcohol), and carboxymethylcellulose with various contents (3–15 mole-%) of substituted repeating units were prepared by polymer-analogous amidation and transesterification of the dimethyl ester of 1a and with N-[2-(N-methylmorpholinio)ethyl]carbodiimide p-toluenesulfonate as coupling reagent. By nucleophilic addition reactions of the pteridinyl amino groups under mild conditions, 1a was bound without cross…